4.6. Cryptophycin-8
In the studies reported, cryptophycin-8 was evaluated for preclinical activity against subcutaneous tumors of both mouse and human origins. Cryptophycin-8 was less potent than cryptophycin-1 by approximately four-fold; however, it was more water soluble and had greater therapeutic efficacy.23